Zilico Ltd is a UK company specialising in the design and manufacture of real-time medical diagnostics to address specific clinical needs. ZedScan™, Zilico's pioneering flagship product utilises Electrical Impedance Spectroscopy (EIS) to improve the ability to detect cervical intraepithelial neoplasia (CIN) following an abnormal smear result, increasing diagnostic accuracy and delivering health economic benefits.

Zilico’s patented EIS technology exploits the different electrical resistivity associated with the cellular structure of normal, pre-cancerous and cancerous tissue, which based on its applicability to other types of neoplasia, substantiates its use as a platform for the rapid, reliable and reproducible detection and diagnosis of disease. Zilico has a number of other products in development including a screening test for cervical cancer and a diagnostic for oral dysplasia. We are interested in meeting with companies who currently sell into the gynaecology and colposcopy markets, for potential distribution ofZedScan™.